Cargando…
Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)
INTRODUCTION: Use of fluorescence imaging in oncology is evolving rapidly, and nontargeted fluorochromes are currently being investigated for clinical application. Here, we investigated whether the degree of tumour angiogenesis can be assessed in vivo by planar and tomographic methods using the perf...
Autores principales: | Wall, Alexander, Persigehl, Thorsten, Hauff, Peter, Licha, Kai, Schirner, Michael, Müller, Silke, von Wallbrunn, Angelika, Matuszewski, Lars, Heindel, Walter, Bremer, Christoph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397521/ https://www.ncbi.nlm.nih.gov/pubmed/18331624 http://dx.doi.org/10.1186/bcr1875 |
Ejemplares similares
-
Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR
por: Höink, Anna, et al.
Publicado: (2019) -
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
por: Dore-Savard, Louis, et al.
Publicado: (2016) -
Transient perfusion in human melanoma xenografts.
por: Tufto, I., et al.
Publicado: (1995) -
Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
por: Yuen, J S P, et al.
Publicado: (2011) -
The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles()
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017)